Fully automated autologous iPSC manufacturing
Reliable production.
Scalable technology.
Cost-effective treatment.
Who are we?
Experts in microfluidics, process automation, stem cell biology bioinformatics, and artificial intelligence from leading European biotech companies and universities.
What we do?
We develop revolutionary technology for low cost, fast, and standardized, automated mass production of autologous iPSCs.
Why iPSCs?
Induced pluripotent stem cells (iPSCs) can be differentiated into any cell type of the body and transplanted without rejection to cure degenerative diseases, cancer, and defective tissues.